Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Body mass index
|
2689 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Chronic Kidney Diseases
|
306 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Congestive heart failure
|
165 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Coronary heart disease
|
1178 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Diabetes
|
710 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.100 | 0.882 | 17 | 2003 | 2019 | |||||
Diabetes Mellitus
|
824 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.100 | 0.842 | 19 | 2003 | 2019 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.030 | 0.667 | 3 | 2004 | 2012 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.900 | 0.906 | 64 | 1998 | 2019 | |||||
Diabetic Polyneuropathies
|
16 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Diabetic Retinopathy
|
213 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Essential Hypertension
|
293 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||
Familial (FPAH)
|
276 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1 | 2003 | 2003 | ||||||
Gestational Diabetes
|
224 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.040 | 0.750 | 4 | 2005 | 2013 | |||||
Heart failure
|
201 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Hypertensive disease
|
1085 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Hypoglycemia
|
42 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.040 | 0.500 | 4 | 2005 | 2019 | |||||
Impaired glucose tolerance
|
81 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.030 | 1.000 | 3 | 2004 | 2009 | |||||
Malignant neoplasm of pancreas
|
277 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Mean blood pressure
|
344 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Metabolic Syndrome X
|
591 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Obesity
|
1111 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.020 | 0.500 | 2 | 2014 | 2015 | |||||
Pancreatic carcinoma
|
322 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Polycystic Ovary Syndrome
|
363 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.020 | 2 | 2007 | 2008 | ||||||
Prediabetes syndrome
|
16 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.020 | 1.000 | 2 | 2011 | 2018 | |||||
Systolic Pressure
|
1931 | 0.701 | 0.360 | 11 | 17388025 | stop gained | T/A;C | snv | 0.64 | 0.700 | 1.000 | 1 | 2016 | 2016 |